Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Lifarizine shows positive results in efficacy/safety study

June 28, 1996

Suntory describes metabotropic glutamate antagonists

June 28, 1996

RPR reports glutamate antagonists

June 28, 1996

NMDA antagonists synthesized by Hoechst Marion Roussel

June 28, 1996

Takeda seeks German approval for idebenone

June 28, 1996

Ampalex proves effective and safe

June 28, 1996

Protein kinase inhibitors reported by Cephalon

June 28, 1996

FDA approves drug/device combination

June 28, 1996

FDA clears Myotrophin early access program

June 28, 1996

MACH discovered by Weizmann Institute

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...